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Background: Antimicrobial resistance is a global health threat, partly driven by inap-
propriate antibiotic prescriptions for acute medical patients in hospitals.
Aim: To provide a systematic review of qualitative research on antibiotic prescribing
decisions in hospitals worldwide, including broad-spectrum antibiotic use.
Methods: A systematic search of qualitative research on antibiotic prescribing for adult
hospital patients published between 2007 and 2017 was conducted. Drawing on the Health
Belief Model, a framework synthesis was conducted to assess threat perceptions associ-
ated with antimicrobial resistance, and perceived benefits and barriers associated with
antibiotic stewardship.
Findings: The risk of antimicrobial resistance was generally perceived to be serious, but
the abstract and long-term nature of its consequences led physicians to doubt personal
susceptibility. While prescribers believed in the benefits of optimizing prescribing, the
direct link between over-prescribing and antimicrobial resistance was questioned, and
prescribers’ behaviour change was frequently considered futile when fighting the complex
problem of antimicrobial resistance. The salience of individual patient risks was a key
barrier to more conservative prescribing. Physicians perceived broad-spectrum antibiotics
to be effective and low risk; prescribing broad-spectrum antibiotics involved low cognitive
demand and enabled physicians to manage patient expectations. Antibiotic prescribing
decisions in low-income countries were shaped by a context of heightened uncertainty and
risk due to poor microbiology and infection control services.
Conclusions: When tackling antimicrobial resistance, the tensions between immediate in-
dividual risks and long-term collective risks need to be taken into account. Efforts to reduce
diagnostic uncertainty and to change risk perceptions will be critical in shifting practice.
ª 2018 The Author(s). Published by Elsevier Ltd
on behalf of The Healthcare Infection Society. This is an open access article
under the CC BY license (http://creativecommons.org/licenses/by/4.0/).nt of Health Sciences, University of Leicester, Leicester LE1 7RH, UK. Tel.: þ44 (0)116 252 3277.
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y Elsevier Ltd on behalf of The Healthcare Infection Society. This is an open access article
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[16,17].Antimicrobial resistance (AMR) is a global problem forecast
to cost more than 10 million lives by 2050 [1]. All antibiotic use
contributes to the development of resistance, and while some
stewardship activities have been successful in reducing anti-
biotic prescriptions in the community, hospital prescriptions
remain on the rise. In the UK, for example, the overall quantity
of antibiotics given to hospital inpatients increased by 5.7%
from 2013 to 2014 [2]. Globally, up to half of all antibiotic
prescriptions for acute medical patients in hospitals are esti-
mated to be inappropriate [3,4]. Inappropriate prescribing in-
cludes prescribing antibiotics when they are not medically
indicated (e.g. for viral illnesses) or prescribing antibiotics for
an inappropriate length of time. An additional problem is un-
necessary prescribing of antibiotics in situations where in-
fections may clear without drug treatment (e.g. bacterial
infections of the throat, including pharyngitis). Finally, inap-
propriate prescribing can refer to the excessive prescribing of
broad-spectrum antibiotics (BSAs), which are effective against
a wider range of pathogens compared with more narrow-
spectrum antibiotics (NSAs), and as a consequence are stron-
ger drivers of AMR [5]. Efforts to address the growing problem
of AMR often target individual prescriber behaviour change,
with a focus on optimizing antibiotic prescribing to reduce
over-use and inappropriate use of antibiotics.
The complexity of changing prescribing behaviour is re-
flected in findings from a review of qualitative literature on
doctors’ antibiotic prescribing decisions across primary and
secondary care, which identified many intrinsic and extrinsic
factors influencing antibiotic prescribing. These included
knowledge and attitudes, sociodemographic factors, patient-
related factors and healthcare-system-related factors [6]. An
important but under-theorized aspect of the problem of
changing prescribing behaviours is the role of risk perceptions
[7]. Medical practice generally involves working practices that
are framed by concepts of risk [8], with practitioner behaviours
underpinned by work to minimize risks to both patients and
practitioners. Understanding perception of (relative) risks, and
how these risks are classified, oriented to and managed in
decision-making processes, is arguably critical for successful
interventions to promote behaviour change [9,10].
This paper reports a systematic review and framework
analysis of qualitative literature on antibiotic prescribing in
hospitals, with an explicit focus on risk perceptions. The Health
Belief Model (HBM) is used as a framework for the analysis
[11e13]. Over the years, repeated evidence has suggested that
this model can explain and predict health-related behaviour
reliably [11,14]. Additional validation of the HBM has been
provided by studies using the model successfully to design
effective health behaviour interventions [15]. The HBM sug-
gests that perceptions of risks and benefits are crucial de-
terminants of health-related behaviours and behaviour
change. Particular risk-related aspects include the perceived
threat of a health risk, jointly determined by the apparent
susceptibility and severity of the risk in question, and the
costebenefit ratio of preventive action including the perceived
effectiveness of a preventative behaviour and the personal
costs or barriers associated with engaging in it (see Figure 1).
The HBM has previously been applied to characterizing patient
and physician perceptions of the threat of AMR, and benefitsThis analysis addressed the research questions:
(1) How are the risks of AMR perceived by prescribers in hos-
pital settings?
(2) What are the perceived benefits of efforts to optimize
antibiotic prescribing behaviour in hospitals, as a strategy
to manage the risk of AMR?
(3) How do perceptions of risk act as facilitators or barriers to
efforts to optimize antibiotic prescribing?Methods
Information sources and search methodology
A systematic literature search of PubMed and Medline was
undertaken for literature published over the past decade (i.e.
between 2007 and 2017). This time frame was chosen to ensure
that the empirical findings reviewed were still relevant to
present-day hospital situations. The following broad search
terms were used: ‘((antibiotic* OR antimicrobial) AND hospi-
tal)’. Filters were applied for qualitative studies (http://
guides.lib.uw.edu/hsl/qualres/pubmed; http://libguides.sph.
uth.tmc.edu/search_filters/ovid_medline_filters). An initial
search was conducted in August 2017, and the search was re-
run in January 2018.
Inclusion criteria
All articles identified through the search were screened
against the following inclusion criteria: (a) reports primary
data; (b) includes findings from qualitative research (e.g. in-
terviews; focus groups; observations); (c) focuses on existing
approaches to decision-making about antibiotic prescribing,
rather than describing or evaluating new antibiotic stewardship
interventions; (d) uses samples of physicians or healthcare
workers (rather than patients or managers); and (e) reports
data collected in adult secondary and tertiary healthcare set-
tings. Paediatric prescribing for children and neonates was
excluded from the review because children typically show
different antibiotic resistance levels, and their prescribing
guidelines differ from adult guidelines (e.g. pertaining to
duration of antibiotics). Articles that focused on surgical pro-
phylaxis were also excluded. To avoid losing studies that could
provide important insights, no exclusions were made on the
basis of quality [18]; no study thatmet the inclusion criteria was
deemed to be fatally flawed, although some papers provided
more findings that were relevant to the research questions, and
so were more heavily weighted in the analysis than others [19].
Analysis
A framework-based synthesis approach was used to analyse
and synthesize the qualitative studies [20]. Under this
approach, analysis uses existing models or theories to create
the framework for the synthesis; this is coupled with inductive,
thematic analysis techniques to capture the complexity of the
data in full. Analysis involved coding all data in the results




























Figure 1. Diagram of Health Belief Model adapted from Glanz et al. (2015).
E.M. Krockow et al. / Journal of Hospital Infection 101 (2019) 428e439430different risk-related aspects of the HBM: (a) susceptibility to
risk; (b) severity of risk; (c) effectiveness of preventative ac-
tion; and (d) barriers to engagement in preventative action.
Perceptions of risks and preventative actions related to soci-
etal outcomes (AMR) were coded, as well as other risks related
to antibiotic prescribing decisions including individual patient
outcomes (e.g. morbidity) and risks to prescribers. The coding
frame was developed iteratively during coding to reflect
emergent themes.Results
In total, 775 articles were identified, and 34 articles were
found to meet the inclusion criteria for the present review.
Details of included articles are shown in Table I. The majority
of the included studies involved research with senior or junior
doctors. Twelve articles reported findings from Australia, seven
from the UK and three from the USA. Only six studies reporting
relevant qualitative findings from low and middle income
countries (LMICs) (Cambodia, India, Ghana, Sri Lanka, China
and Vietnam) were identified. The vast majority of studies
(N ¼ 25) used interviews, five studies employed focus groups,
and the rest adopted a combination of qualitative methods.
This article presents the results from the framework syn-
thesis, providing an overview of the evidence on perceived
severity of, and susceptibility to, the consequences of AMR in
hospital settings, and describing perceived benefits and bar-
riers to optimizing antibiotic prescribing behaviour in hospitals
as a preventative action. Illustrative quotes for each theme are
provided in Table II; all quotes are labelled with unique
numbers. To link the quotes to the relevant text below, quote
numbers are included in parentheses.AMR as a health threat: perceived severity
Health professionals working in hospital settings are, on the
whole, aware of the threat of AMR as a serious problem with
potentially severe consequences (1a) [7,21]. They recognize
the potential for AMR to pose a devastating global health threat
e a future ‘antibiotic apocalypse’ [22] in which commonly used
antibiotics would no longer be effective, and untreatable in-
fections would be widespread. They also acknowledge that, in
the shorter term, growing levels of resistance could make it
more difficult to treat patients, with some patients not
responding to first-line treatment but requiring protracted
treatment with higher doses or multiple antibiotics (1b)
[21,23], increasing the risk of negative patient outcomes as
well as cost.
AMR as a health threat: perceived susceptibility
Despitewidespread recognition of the risks of AMR, a common
theme in the literature is that of low perceived susceptibility to
these risks in the context of everyday practice. There is evidence
that some staff are disinterested in the topic [24]. Staff tend not
to see themselves as susceptible to the risks of resistancedue to a
lack of imminence and the abstract nature of their consequences
(2a) [22,24]. So long as they can continue to treat patients
effectively with antibiotics, AMR remains a distant problem that
does not pose an immediate or pressing risk for themselves or
their patients, and can be bracketed out as a source of worry
[7,22,25e28]. This lack of perception of susceptibility is
bolstered by a general lack of awareness of the current scale of
resistance and of local resistance patterns (2b) [7,29].
Exceptions to these widespread perceptions of low
perceived susceptibility come from accounts of staff who have
Table I
Overview and summary variables of all qualitative studies reviewed in this article (in alphabetical order of authors)
Authors Country Method Sample Focal topic
Type Size
Almatar et al. (2014) [55] Australia Interviews Different doctors 8 Antibiotic use for treating pneumonia
Asante et al. (2017) [21] Ghana Interviews Multiple 33 Antibiotic prescribing in hospitals
Björkman et al. (2010) [24] Sweden Interviews Different doctors 20 Identifying ‘antibiotic prescriber types’ of doctors
Broom et al. (2016) [44] UK Interviews Different doctors 20 Intravenous to oral antibiotic switch
Adherence to antibiotic prescribing guidelines and AMSBroom et al. (2016) [42]*
Broom et al. (2014) [7] Australia Interviews Different doctors 30 Antibiotic prescribing in hospitals
Broom et al. (2015) [40]
Broom et al. (2015a) [28] Australia Interviews Pharmacists 19 Role of pharmacists in antibiotic prescribing
Broom et al. (2015b) [25]
Broom et al. (2016) [27]*
Broom et al. (2016) [26] Australia Interviews Nurses 30 Role of nurses in antibiotic prescribing
Broom et al. (2017) [22] UK Interviews Multiple 28 Antibiotic use in hospital pulmonary infections
Broom et al. (2017) [36] Australia Interviews Different doctors 64 Antibiotic prescribing in hospitals
Broom et al. (2017) [43] Australia Interviews Multiple 30 Antibiotic prescribing in remote settings
Broom et al. (2017) [52] Australia Focus groups Multiple 29 Antibiotic prescribing in hospitals
Charani et al. (2013) [46] UK Interviews Multiple 39 Prescribing etiquette as determinant of antibiotic prescribing
Cotta et al. (2015) [50] Australia Focus groups Multiple 17 Adherence to antibiotic prescribing guidelines and AMS
Eyer et al. (2016) [39] Switzerland Interviews Different doctors 21 Antibiotic use for treating asymptomatic bacteriuria
Livorsi et al. (2015) [38] USA Interviews Different doctors 30 Antibiotic prescribing in hospitals
Livorsi et al. (2016) [53] USA Interviews Different doctors 30 Adherence to antibiotic prescribing guidelines and AMS
Mattick et al. (2014) [56] UK Interviews Junior doctors 33 Antibiotic prescribing in hospitals
May et al. (2014) [30] USA Mixed qualitative methods Multiple 31 Antibiotic prescribing in hospitals
Nguyen et al. (2009) [37] Vietnam Mixed qualitative methods Multiple 20 Antibiotic use for treating reproductive tract infections
Om et al. (2016) [34] Cambodia Focus groups Different doctors 103 Antibiotic prescribing in hospitals
Ravi et al. (2017) [33] India Interviews Senior doctors 5 Antibiotic prescribing in hospitals
Reynolds and McKee (2009) [23] China Interviews Multiple 18 Antibiotic prescribing in hospitals
Rawson et al. (2016) UK Interviews Different doctors 20 Mapping the decision pathway of acute infection management
Schouten et al. (2007) [54] The Netherlands Mixed qualitative methods Multiple 24 Antibiotic use for treating pneumonia
Sedrak et al. (2017) [32] Australia Interviews Senior doctors 10 Antibiotic use for treating pneumonia
Skodvin et al. (2015) [51] Norway Interviews Different doctors 15 Antibiotic prescribing in hospitals
Tillekeratne et al. (2017) [29] Sri Lanka Interviews Multiple 55 Antibiotic use for treating reproductive tract infections
Tonna et al. (2010) [35] UK Focus groups Pharmacists 14 Role of pharmacists in antibiotic prescribing
Velasco et al. (2011) [31] Germany Focus groups Different doctors 14 Antibiotic prescribing in hospitals
Warburton et al. (2014) [57] UK Mixed qualitative methods Multiple 16 Intravenous to oral antibiotic switch
AMS, antimicrobial stewardship.









































Severity High perceived severity of AMR (1a) ‘That is the most danger s thing that can happen to mankind.
We may move to the last limi where we cannot get any antibiotics
to treat certain diseases.’ [21
(1b) ‘Antibiotic dosages have sen greatly. This is because people
have some substance in their odies which can resist the drug. If
[a patient] can be treated by ne pill the first time, the second time
it takes two pills and the thir time three pills.’ [23]
Susceptibility Low perceived personal susceptibility to negative
consequences of AMR
Perceived susceptibility heightened by personal
experience of consequences of AMR
(2a) ‘So [resistance] it’s some hing, if something’s not affecting you
straightaway you tend to put off and put it off and I think
that’s sort of what’s happene , is what happens.’ [28]
(2b) ‘We don’t have the big p ture, so we don’t worry as
much [.] about resistance p terns, about community-wide use of
antibiotics.’ [7]
(2c) ‘I think people should be eally worried about it [AMR]. I’m aware
of it. [.] Often you’ll hear [ ople] look up
sensitivities and talk about it nd go, ‘Oh my god, they’re resistant
to just about everything. The ’s nothing left,’ and you’re like,
‘Oh s***’.’ (Female, general m dicine, clinical nurse)’ [26]
(2d) ‘You know, we’re seeing RE, we’re seeing MRSA, we are seeing
these things, and we’re seein them more and more. [.] And if you
know that your antibiotic pre ribing patterns potentially affect that,
and all the pain that goes wit it. Like my unit’s closed again at the
moment, because someone c e over from [location] with VRE now






Benefits Optimizing antibiotic use perceived to have
the potential to reduce AMR
Scepticism about impact of targeting hospital
prescribing
Other issues seen as more critical to
address in tackling AMR
(3a) ‘Every day, doctors are n t performing appropriately. We have made
lots of mistakes with our anti oticprescribing.’ [34]
(3b) ‘I think [stewardship is] mething that helps us curb inappropriate
antibiotic usage, and it’s nec sary in all hospitals, I think, private and
public, yeah.’ [32]
(3c) ‘I just think in the grand heme of things how much effect is
[antibiotic misuse] having, or ow much protection of antibiotics and
reduction of resistance is [ste ardship] actually creating?’ [25]
(3d) ‘Antibiotic resistance is ssible because in Ghana .., you can
go to any drug store and buy y antibiotics without any prescription or
these days we don’t know th source of medication that we are getting
whether they are the correct r the fake ones. The efficacy level is
questionable.’ [21]
(3e) ‘We think our practice d sn’t comply with infection control
guidelines. [.] When we kno that our practices are not correct








































































AMR risk loosely coupled to prescribing decision
Short-term risks of antibiotic prescribing decision
for individual patient and prescriber take
precedence
Reliance on BSAs helps manage risk in conditions
of uncertainty and requires less cognitive effort
Decisions influenced by access to resources to
manage risk and uncertainty
(4a) ‘But actually, about antibiotic resistance, so far I have no
experience. Just by treating patients very often, we give treatment
for three or four days. After that sometimes they won’t come to us.
But bit difficult to assess whether they have developed antibiotic
resistance or not.’ [29]
(4b) ‘The clinician is ultimately responsible for the patient’s care, so
if something’s not done. [.].Well I’m responsible, [.] if this person
dies it’s me that faces the consequences.’ [42]
(4c) ‘I actually have been criticized by a staff because of not covering
somebody [with antibiotics] .I was suspicious for endocarditis but
they were clinically stable and so I wanted to get multiple blood
cultures and monitor.The next morning I was pretty severely
reamed out [(reprimanded)] for not covering the patient [with
antibiotics], although the person did fine and did not have a bad
clinical result.’ (12, resident interview) [38]
(4d) ‘If I am not prescribing an antibiotic from the first day, sometimes
it can be a bacterial one [infection], and on the second, third day the
patient will get more severe symptoms and go to another practitioner.
Then [the practitioner will say] ‘this is pneumonia’ and they will start
[antibiotics]. [.] Mother or some relative will say that this is the best
physician [..] His treatment is much better than the other one, then
the first person will get less respect. Because of competition, most of
the time in the private sector, they use antibiotics.’ [29]
(4e) ‘I think that we, because of uncertainty, may be somewhat more
active. And for the same reason that we sometimes give more
BSAs than they do for example at the
department of infectious diseases [.] When you do not know,
you use something stronger.’ [24]
(4f) ‘Ceftriaxone is a fire and forget weapon. Give it, then the patient
gets better . and there are very rare major side effects acutely.
I guess people think that they cover their back by giving
ceftriaxone.’ [55]
(4g) ‘Patients want ‘quality’ medicine. They don’t say ‘ceftri
[ceftriaxone]’ they just say that they want ‘quality’ medicine. With
stronger medicine, they believe they recover faster.’ [34]
(4h) ‘When it is 3:00 in the morning, depending on how busy you are,
the easiest solution is to throw vancomycin and piperacillin-
tazobactam at every patient because you do not have time to
read the confusing guidelines that tell you 16 different things you
would potentially do.’ [38]
(4i) ‘Lab tests have their limitations. I think it is subjective because
it requires quality reagents and skilled and well-trained technicians
to read the result. Not many of our lab technicians have such
qualifications.’ [49]



































E.M. Krockow et al. / Journal of Hospital Infection 101 (2019) 428e439434had direct evidence of how they or their hospital have been
exposed to negative consequences arising from the growing
problem of resistance. Evidence from clinical experience of
cases where AMR is already posing a serious risk to patients or
causing problems in practice, rather than just being an abstract
future threat, is particularly powerful in promoting a height-
ened sense of susceptibility (2c, 2d) [7,26]. Concern about AMR
also tends to be greater in individuals who have a direct in-
terest and expertise in infections and microbiology, and thus a
better understanding of the problem and the current extent of
resistance in the clinical population [24,30,31].Optimizing antibiotic prescribing behaviour:
perceived effectiveness in reducing the risk of AMR
The majority of staff recognize that inappropriate use of
antibiotics, and over-reliance on BSAs, are problematic, and
accept that initiatives are needed within hospitals to try to
rationalize antibiotic use and change prescriber behaviour
(3a, 3b) [32,33]. In LMIC settings in particular, there is concern
that levels of inappropriate antibiotic prescribing are high
[34]. Optimizing antibiotic prescribing, to reduce antibiotic
over-use, is seen as a legitimate aspiration in health care [21],
and as potentially bringing additional benefits, including
ensuring more appropriate patient care, and reducing costs
and length of stay [35]. There is also some scepticism, how-
ever, about the extent of benefit in terms of reducing the
spread of resistance that can be achieved through a focus on
optimizing antibiotic prescribing practice within hospitals (3c)
[28]. A belief in the benefits of this approach as a means of
reducing the risk of resistance can be undermined by a lack of
hard evidence that reducing prescribing in hospitals will
reduce the spread of resistance, and a perception that the
problem is too complex [26].
In addition, prescribers are not always convinced that they
themselves, or their hospital, are part of the problem, and
hence may not feel they have a responsibility to change their
practice [7,22,32,36]. This issue is compounded by a lack of
feedback to prescribers about the quality of their prescribing,
and a lack of information about local prescribing and resistance
patterns. Prescribers commonly argue that the main causes of
resistance lie beyond over-prescribing of antibiotics in hospi-
tals, and that other solutions will have more effect. The latter is
a common theme in the literature from LMICs. In some LMIC
contexts, patients can buy antibiotics or obtain them easily
through informal channels outside of the hospital, resulting in
unregulated antibiotic use, and there is widespread concern
about the quality of antibiotics and under-dosing [21,23]. These
issues are seen as major contributing factors to resistance,
making any efforts to address the risk of growing resistance
through curbing antibiotic prescribing in hospitals seem futile
(3d). In addition, focusing on infection control is argued by some
to be a more immediate and effective solution in the fight
against resistance, due to the important role that infection
control can play in reducing the spread of resistant bacteria
[31,34]. In LMICs, where hygiene standards are perceived to be
relatively low, efforts to reduce antibiotic prescribing are ex-
pected to be ineffective without improved hygiene and infec-
tion control, as staff feel compelled to prescribe antibiotics to
avoid infections due to unclean environments and poor infec-
tion control practices (3e) [34,37].Barriers to optimizing antibiotic prescribing behaviour
The literature included in this review focused over-
whelmingly on exploring the barriers to changing antibiotic
prescribing behaviours, which are multiple and varied. Two
risk-related themes run through the literature and underpin
many of the challenges to optimizing antibiotic prescribing
behaviour: antibiotic over-prescribing reflects a trade-off be-
tween individual risks and societal risks; and reliance on the
use of BSAs helps manage immediate risk in conditions of un-
certainty, and minimizes cognitive effort.
Over-use of antibiotics: perceptions of immediate risk
A significant perceived barrier to individual prescriber
behaviour change arises from the nature of the link between
individual prescribing behaviour and AMR as an outcome. While
the majority of staff are aware, in principle, that their anti-
biotic prescribing actions can contribute to AMR, in practice,
the link between individual antibiotic prescribing decisions and
AMR is not immediate or apparent. In the context of their
everyday practice, the risk of AMR as an outcome is loosely
coupled [9] to the discrete event of decision-making about
antibiotic prescribing for an individual patient (4a). In contrast,
the risks that loom large for prescribers in making antibiotic
prescribing decisions relate more to the immediate conse-
quences of their decisions for individual patient outcomes:
outcomes which are tightly coupled to the doctor’s actions,
and potentially severe, and therefore strongly shape the
decision-making process [36].
Decisions about whether or not to prescribe antibiotics are
heavily influenced by fears of missing bacterial infections or
sepsis, with potentially serious consequences for patients,
including death [7,38e40]. The concern about the individual
patient lies at the core of the medical profession; doctors feel
strongly that they have a duty of care to their patients [41], and
that they have a responsibility to make decisions that are most
likely to lead to a positive outcome of the individual patient in
front of them (4b) [42]. When doctors have any suspicion of
infection, even if this is not confirmed by laboratory results,
they may be unwilling to take the risk of holding off from
treating a patient [39]. Furthermore, doctors consider local
patient populations and adapt prescribing choices to particu-
larities of their location. In the remote Australian outback, for
example, where patient compliance of indigenous patient
groups is low and attendance of follow-up medical appoint-
ments is rare, doctors frequently over-prescribe antibiotics to
prevent any complications [43].
The consequences of antibiotic prescribing decisions for
prescribers themselves are closely linked to patient outcomes.
Doctors perceive themselves to be susceptible to risks associ-
ated with negative patient outcomes including complaints and
litigation [36,38,44], damage to professional reputation or
attracting disapproval from colleagues or supervisors
[40,45,46], and emotional responses to patient complications
[7]. Being seen to under-treat can in itself give rise to negative
consequences for doctors, even if this ultimately has no impact
on the patients’ condition (4c) [38]. Doctors describe experi-
ences of being criticized as a result of decisions not to treat
[38]; in contrast, conservative antibiotic decision-making is
rarely made visible or praised [39].
Considerations around risk are most salient for junior doc-
tors, who typically report higher risk perceptions than senior
E.M. Krockow et al. / Journal of Hospital Infection 101 (2019) 428e439 435consultants, especially in situations with high clinical uncer-
tainty [39], and often face the challenge of making prescribing
decisions in the absence of senior support (e.g. during night
shifts) [45]. Junior doctors are acutely sensitive to the need to
develop and maintain their reputations as competent doctors,
and to avoid being reprimanded by their seniors for delaying
treatment or putting a patient at risk, and in situations of un-
certainty, choosing to start antibiotics can seem to be the
easiest and safest option [30,39]. Senior doctors’ preferences
and expectations, and local prescribing norms, [26,32,38,42,45]
also shape junior doctors’ prescribing decisions; junior doctors
risk facing social sanctions associated with committing a so-
called ‘quasi-normative error’ [47] if a decision not to pre-
scribe, or to delay prescribing until microbiological results are
available, is at odds with local norms and expectations.
Antibiotics also have latent functions [48] beyond the direct
benefit of preventing patient morbidity. The interests of doc-
tors are bound in to the service relationship of demand and
supply, and antibiotic prescribing forms part of this relation-
ship. Doctors can feel under pressure to give antibiotics to
satisfy perceived patient and carer demand [34], and avoid the
risk of damaging their relationships with patients and carers
[7]. Protecting relationships with patients, and more impor-
tantly doctors’ professional reputations, is important for doc-
tors working in private healthcare systems, who may face risks
of losing patients and income if patients are dissatisfied with
not receiving antibiotics (4d) [29,30,32,34,38,39,45,49e51].
In making prescribing decisions under conditions of uncer-
tainty, doctors may consciously consider the risks of prescribing
(in particular, over-prescribing) antibiotics, including AMR, but
the risks of negative patient outcomes and corresponding per-
sonal and professional risks that could arise from failing to treat
with antibiotics are oftenmore heavily weighted in the decision
[7,38]. This leads doctors to adopt approaches of ‘defensive
medicine’ [52]. Ultimately, concern about short-term risks, and
desire for short-term benefit, tend to trump any concern about
longer-term consequences for wider society.
Over-use of broad-spectrum antibiotics: managing
uncertainty and reducing cognitive effort
Initial decision-making about whether or not to start an
antibiotic is generally based on clinical judgement about
whether an infection is likely, rather than on microbiological
evidence of infection. The majority of antibiotic prescribing is
empirical, and choice of antibiotic is underpinned by a desire
to give a treatment with the best chance of success. Although
over-use of BSAs can disproportionately contribute to resis-
tance, in practice, these types of antibiotics are an attractive
choice. They are seen to offer the best level of protection from
various risks. The use of a BSA helps doctors feel reassured that
they are ‘covering all bases’ [38], especially when they have
concerns about infection but are uncertain about the potential
source; whatever the cause of an infection, a BSA is likely to be
effective (4e, 4f, 4g). The use of BSAs, seen as powerful and, in
some cases, ‘mythical’ drugs [34,52], is typically considered by
prescribers to outweigh any costs [38] and, particularly in LMIC
settings, to enable them to satisfy perceived patient demand
for strong and high-quality medication (4g) [21,29,34]. On the
whole, BSAs appear to promise faster patient recovery [24,34]
and preservation of hospital resources [23].
Taking into account the risks of under-treatment discussed
above, doctors may consider the need to reduce reliance onBSAs, but concerns about the risk of choosing an NSAwhich may
‘miss a bug’ [38,53,54] and prove to be ineffective are more
salient. Treating according to guidelines is seen to offer some
protection against this risk [51], but requires that up-to-date
guidelines are available and accessible, and that doctors
have the time and motivation to engage with them. This ten-
dency to rely on BSAs is reinforced for doctors who have
personally experienced problems when targeted antibiotics
resulted in negative patient outcomes [29,34,43,55]; this is
another issue that is particularly prominent in the literature
from LMIC settings.
As prescribing BSAs is seen as a low-risk and low-cost activity
in the short term, the decision-making process may be afforded
little priority or attention. In choosing a BSA, decision-making
about treatment can be undertaken quickly and with little
cognitive effort [7,36], avoiding the need for complex decision-
making (4h) [30,38] or disturbing senior doctors or specialist
prescribers for advice [22,56]. Choosing to prescribe antibiotics,
particularly BSAs, under conditions of uncertainty is seen as a
quick, safe [54,55] and effective way to start treatment [39]
when doctors are under pressure or short of time (4h) (espe-
cially out of hours [7,32,38,55]), or when they lack expertise or
confidence in antibiotic selection [24,34].
Microbiological testing is perceived to play an important
role in reducing uncertainty, but samples are not always taken
reliably prior to commencing antibiotic treatment, and results
may be inconclusive or delayed beyond the point at which a
treatment decision needs to be made. Antibiotic prescriptions
do not always get reviewed, which is a particularly frequent
problem at weekends [57]. Even when laboratory results are
available, doctors are often unwilling to take the risk of stop-
ping successful treatment with a BSA [45,53] or replacing it
with an NSA, describing a belief that they should ‘never change
a winning team’ [26,53]. In LMIC settings in particular, re-
sources to reduce uncertainty and guide decision making are
often lacking; lack of access to good-quality laboratory testing
(4i), poor infrastructure and lack of engagement with testing
[21,29,34,49], and insufficient training and information about
diagnoses of infections [21,29,33,49] are common problems. A
lack of access to appropriate prescribing guidelines [34,49] can
also contribute to making it difficult for prescribers to make
conservative and tailored prescribing decisions. Under these
circumstances, prescribing decisions are routinely made as
best guesses under conditions of uncertainty, where erring on
the side of caution e over-prescribing of antibiotics and over-
reliance on BSAs e is a rational response.
While the risks of optimizing antibiotic prescribing loomed
large and presented significant barriers to behaviour change,
few prescribers across the studies suggested specific facilita-
tors for more appropriate use of BSAs. Prescribers across
several studies emphasized the importance of expert input
from antimicrobial pharmacists [28,35,38], and maintaining
good relations with microbiology services [31,38,45]. Others
suggested the need for an overall change of existing healthcare
systems [24] and support for doctors to manage risk more
effectively [51].Discussion
This systematic review provides a new, theory-informed
description of perceptions of risk in relation to AMR and
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model which predicts that health-related behaviours only
change if the health risks are perceived to be a serious threat
and if these risks are thought to be manageable. Evidence from
34 qualitative studies across high-income countries and LMICs
was used to identify themes in relation to risk and perceptions
of preventative actions.
While AMR risk is generally perceived by hospital staff to be
very severe, perceptions of personal susceptibility are limited.
Staff report some scepticism about the potential benefits of
targeting hospital antibiotic prescribing as a strategy for
reducing the threat of AMR. Doctors’ accounts demonstrate
rational and contextually embedded reasons for antibiotic
over-use and over-reliance on BSAs, arising from the need to
make decisions under conditions of uncertainty, and to manage
risks to patients and to themselves as professionals e risks
which are seen as more immediate, pressing and visible than
the future abstract threat of AMR. Prescribing antibiotics,
particularly BSAs, is characterized as a quick and easy strategy
to manage short-term risks and gain short-term benefit, with
minimal cognitive demand.
At the core of the problem of unnecessary or inappropriate
prescriptions of antibiotics lies the much-discussed social
dilemma of two different stakeholders with mutually exclusive
interests [58e60]. One stakeholder is the individual patient
with a suspected bacterial infection, and the other stakeholder
is global human society. Antibiotic use has a range of implica-
tions in terms of the interests and risks for individual patients,
related risks and consequences for doctors as professionals, and
longer-term consequences for society [61,62]. These findings
provide a description of how prescribers weigh these risks, and
illustrate how prescribing behaviour is heavily (and rationally)
weighted towards the avoidance of tangible, immediate and
short-term risks, at the cost of the potentially catastrophic, but
abstract and uncertain, future outcome of widespread AMR.
This prioritizing of short-term, concrete risks, and discounting
of abstract future risks has long been recognized as a core
feature of human psychology, and it is critical that this tension
is taken into account in designing interventions to try to opti-
mize prescribing behaviours. There is potential value in
considering channels and mechanisms through which the risk
perception of AMR could be amplified [63] and made more im-
mediatee particularly given that prescribers are often unaware
of the existing scale of AMR at the present time e and that ef-
forts to optimize prescribing are backed up by evidence, which
is currently lacking, that this strategy is effective in slowing the
development and spread of resistance. Efforts to change
behaviour may also need to consider how to make visible, and
reward, conservative prescribing, and how to manage percep-
tions of risk associated with decisions not to prescribe; for
example, through organizational protection from personal liti-
gation. Clearly, developing technology to support improved
diagnostic testing, and ensuring that resources are committed
to the provision of microbiology services in LMICs in particular,
will also play an important role in reducing the extent to which
antibiotic prescribing decisions have to be made under condi-
tions of uncertainty. In fact, improved access to expert support
from microbiology services and pharmacists was the only
facilitator for more optimal prescribing suggested consistently
by study participants [28,31,35,38,45].
Making the case for changing behaviour to address the threat
of AMR is also hampered by the fact that practitioners tend todownplay the risk of AMR in relation to their individual pre-
scribing decisions and their own organization, and to charac-
terize it as a problem caused by others [17,64,65]. Feedback on
prescribing patterns may help drive a recognition of personal
responsibility. Hospital staffmay feel that they have good reason
to look elsewhere for the solution to the problem, including
antibiotic use in the community and in primary care; this is a
particular problem in many LMICs, with non-prescription anti-
biotic use accounting for between 19% and 100% of antimicrobial
use outside of northern Europe and North America [66]. Struc-
tures to enable cross-sector cooperation between community
organizations, primary and secondary care providers, and pri-
vate and public sector healthcare providers may be a partial
answer to this problem [67]. Overall, tackling AMR in LMICs needs
amore complex approach than inmore developed countries; any
interventions for behavioural change in prescribing also need to
be accompanied by a tightening of antibiotic sales regulations
and improvements of general hygiene levels.
This review is limited by the scope and scale of qualitative
research on perceptions of AMR and antimicrobial prescribing
that could be drawn upon in the analysis and synthesis. The
majority of the included papers focused on barriers to changing
antibiotic prescribing behaviour; few qualitative studies that
looked at hospital staff perceptions of resistance were identi-
fied, although the interpretation of the qualitative data aligns
with findings from survey studies [68e70]. All papers that met
the inclusion criteria were included, but the quality of the
included papers was variable and some contributed more
relevant findings to the synthesis than others. Some of the
studies included non-prescribers such as nurses and pharma-
cists, and these were drawn upon for additional insights into
the perceptions and actions of prescribers, as opposed to
exploring the diverse perceptions across different staff groups.
The focus of this review was on individual perceptions; as such,
the authors did not set out to study the broader cultural and
contextual influences on antibiotic use [71], although the
findings highlight how the social, organizational and national
healthcare context can impact on perceptions of immediate
and long-term risks, and commitment to and possibilities for
preventative action against AMR.
Although qualitative studies from 13 different countries
were identified, the majority of qualitative research on anti-
biotic prescribing in hospitals comes from highly developed
nations such as Australia, the UK and the USA. In fact, 12
studies [7,22,25e28,36,40,42e44,52] included in this review
were co-authored by a single research group based in Australia,
which could have led to a bias in the results and conclusion due
to the disproportionate representation of Australian samples in
this review. Only six studies of developing countries matched
the inclusion criteria for this review, most of which focused on
South-east Asia. The very different prescribing contexts in
LMICs, which can include unregulated antibiotic availability
and severely limited resources for diagnostic testing and
monitoring of patients [72], shape the way that risks are
framed and the way they can be managed. Surprisingly, no
study to date has conducted a direct cross-cultural comparison
of antibiotic prescribing decisions, and how these are impacted
on by context, and the vast majority of studies continue to
focus on industrialized nations. Future studies should address
this research gap by conducting carefully designed cross-
cultural research projects comparing countries of varying
development levels across different continents.
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been conducted in public hospitals, despite the fact that
countries such as the USA and many developing countries have
a large sector of privately funded health care. The current
review demonstrated important sector-specific pressures and
incentives that shape prescribing decision-making, related to
prescriber autonomy, patient demand and competition be-
tween private healthcare facilities, which could strongly drive
up antibiotic prescribing rates. Further research into changing
prescriber behaviour in the specific context of private health-
care provision would be of value [73].
In conclusion, AMR is a global health challenge that needs to
be addressed urgently; optimizing the use of antibiotics in
hospital settings is an important element of strategies for pre-
serving antibiotics for the future and limiting the growth of
resistance. Despite widespread recognition of the potential
severity of AMR, commitment to efforts to optimize antibiotic
prescribing by hospital prescribers is undermined by a lack of
personal susceptibility and scepticism about the benefits of this
approach as a preventative action. Over-prescription of anti-
biotics reflects prescribers’ focus on minimizing short-term in-
dividual risk in their day-to-day prescribing decisions. Previous
research [7,40] has identified that perceptions of clinical un-
certainty, and fear of immediate risks, drive over-use of anti-
biotics; this review further develops the role of risk perceptions
in antibiotic use by highlighting the way in which individual
prescribers perceive, manage and balance different risks in
their decisions about antibiotic prescribing. In developing in-
terventions to reduce the threat of AMR by optimizing antibiotic
prescribing, there is a need to consider the tensions between
immediate individual risks and long-term collective risks, and
consider how risks can be changed to shift practice; one way of
achieving this could be to highlight existing individual risks from
over-prescribing, such as side effects and increased levels of
individual resistance levels, which are often downplayed. There
is also a need to explore approaches to promoting cooperative
action between organizations, and to develop mechanisms for
feedback to prescribers about prescribing patterns, as well as
evidence of the impact of improved antibiotic prescribing on
the development and spread of resistance.
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